Patents
Literature
2 results about "Entry inhibitor" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Entry inhibitors, also known as fusion inhibitors, are a class of antiretroviral drugs, used in combination therapy for the treatment of HIV infection. This class of drugs interferes with the binding, fusion and entry of an HIV virion to a human cell. By blocking this step in HIV's replication cycle, such agents slow the progression from HIV infection to AIDS.
Virus cell entry inhibitor
The present invention addresses the problem of providing a virus cell entry inhibitor that inhibits the entry of viruses into cells and makes it possible to prevent viral infections. A virus cell entry inhibitor that solves the problem of the present invention is characterized by containing at least one selected from an eyebright extract, a kasoori methi extract, a Tartary buckwheat extract, an okra extract, a cinnamon extract, a berberry extract, and a shell ginger extract.
Owner:YAKULT HONSHA KK
Medicines and methods for clearing cccdna from the liver of hepatitis b virus infected individuals
PendingCN122163807APeptide/protein ingredientsDigestive systemImmunomodulating AgentHepatitis B virus
This invention relates to pharmaceuticals and methods for clearing hepatitis B virus (HBV) cccDNA from the livers of hepatitis B virus-infected individuals. Specifically, this invention provides the use of HBV entry inhibitors that inhibit HBV entry into hepatocytes and, optionally, immunomodulatory agents that regulate anti-HBV immunity in the preparation of pharmaceutical combinations or kits used in methods for clearing HBV cccDNA from hepatitis B patients. This invention also provides corresponding pharmaceutical combinations and kits for the above-mentioned uses.
Owner:SHANGHAI HEP PHARMA